본문 바로가기

Biomarkers in metabolic syndrome

문서 유형
연구출판물 · 저서
등재
SCIEScopus
저널 순위
JCR Q1Scopus Q1
저널
ADVANCES IN CLINICAL CHEMISTRY111 · pp.101 · 2022
피인용
Scopus 25
FWCI (Scopus)
5.9
JCR IF
JCR 2021 6.303
ISSN
0065-2423

저자

  1. 조영혜제1저자Department of Family Medicine and Biomedical Research Institute, Pusan National University Yangsan Hospital, Yangsan, South Korea
  2. 이영인Department of Family Medicine and Biomedical Research Institute, Pusan National University Yangsan Hospital, Yangsan, South Korea
  3. 최정인Department of Family Medicine and Biomedical Research Institute, Pusan National University Yangsan Hospital, Yangsan, South Korea
  4. 이새롬Department of Family Medicine and Biomedical Research Institute, Pusan National University Yangsan Hospital, Yangsan, South Korea
  5. 이상엽교신저자Department of Medical Education, Pusan National University School of Medicine, Yangsan, South Korea

초록

© 2022 Elsevier Inc.Metabolic syndrome (MetS) is a global health challenge characterized as a group of risk factors for developing atherosclerotic cardiovascular disease. Although visceral adipose tissue, adipocyte dysfunction, chronic low-grade inflammation, and insulin resistance are fundamental to MetS, the exact biochemical mechanisms underlying this disease state remain unclear. Numerous biomarkers, however, have been proposed to improve our understanding of its complex pathophysiology and facilitate diagnosis. This review examines these biomarkers and clarifies their potential roles in the pathogenesis, diagnosis, prediction, progression, and severity of MetS and MetS-related disorders.

키워드

AdipocytokineBiomarkersInflammationInsulin resistanceLipoproteinMetabolic syndromeOxidative stressVisceral adipose tissue

식별자

Scopus EID
2-s2.0-85137722285